Frederiksberg, Denmark

Christian Klarner Sams

This inventor holds 20 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 10 EPO patents, primarily in Biochemical Synthesis. Top assignees: Nuevolution A/s, Novo Nordisk A/s, Neuvolution A/s. Active years: 2003-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian Klarner Sams. Retrieved from https://idiyas.com/inventor/christian-klarner-sams

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 45.0


 

Average Co-Inventor Count = 10.6

ph-index = 12

Forward Citations = 573(Granted Patents)


Location History:

  • Frederiksberg C, DK (2010 - 2015)
  • Værløse, DK (2017 - 2019)
  • Frederiksberg, DK (2003 - 2020)
  • Vaerloese, DK (2012 - 2021)
  • Væløse, DK (2023)

Company Filing History:


Years Active: 2003-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Enzymatic Encoding
Bifunctional Complex
Templated Molecules
Heterocyclic Compounds
DPP-IV Inhibitors
Glucagon Antagonists
Biochemical Methods
Molecular Synthesis
Chemical Libraries
Pharmaceutical Chemistry
20 patents (USPTO):Explore Patents

Title: Christian Klarner Sams: Innovator in Enzymatic Encoding

Introduction

Christian Klarner Sams, based in Frederiksberg, Denmark, is a prominent inventor known for his contributions to biotechnology and enzymatic processes. With a remarkable portfolio of 20 patents, his work has significantly impacted the field of synthetic methods and molecular biology.

Latest Patents

Among his latest contributions, two notable patents stand out. The first is titled "Enzymatic encoding methods for efficient synthesis of large libraries." This patent discloses a novel method for creating a bifunctional complex that links a molecule to a single-stranded identifier oligonucleotide. This method involves a two-step process where a nascent bifunctional complex is reacted with reactants at a chemical reaction site and tagged enzymatically at a priming site, allowing for precise identification of the reactants.

The second patent, "Method for the synthesis of a bifunctional complex," describes a similar approach but emphasizes the combination of a display molecule part and a coding part. This technique also employs enzymatic processes to tag reactants, enhancing the efficiency and specificity of complex synthesis.

Career Highlights

Christian has had an impressive career in companies at the forefront of biotechnology, including Nuevolution A/S and Novo Nordisk A/S. His expertise in enzymatic methods and complex synthesis has positioned him as a leader in the innovative landscape of biotechnology research.

Collaborations

Throughout his career, Christian has collaborated with several talented individuals, including his coworkers Thomas Franch and Jakob Felding. These partnerships have fostered a creative environment, driving advancements in their mutual fields of research.

Conclusion

In summary, Christian Klarner Sams exemplifies the pioneering spirit of innovation within the biotechnology sector. His extensive patent portfolio and collaborative efforts highlight his significant contributions to enzymatic applications and complex synthesis. As the field continues to evolve, inventors like Christian will play a crucial role in shaping the future of scientific discovery and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…